Durata appoints new chairman and independent director
Smith & Nephew (FTSE:SN, NYSE:SNN) Durata Therapeutics announced the appointment of Richard De Schutter as the company’s new chairman and independent director. Following this announcement, the company was also listed on the NASDAQ effective July 17, 2012.
NanoString adds Greg Norden to board of directors
NanoString Technologies announced the appointment of Greg Norden, former CFO of Wyeth Pharmaceuticals, to its board of directors. Norden will serve as chairman of the company’s audit committee.
Hospira elects industry veteran Dennis Fenton to board
Hospira (NYSE:HSP) named healthcare industry veteran Dennis Fenton to its board of directors, expanding the team from 10 to 11 members.